1. Neurotoxicity associated with spinal drug delivery

   Newsletter Article 09 February 2013 Pages: 2 - 2

2. Benzyl alcohol preservative

   Newsletter Article 09 February 2013 Pages: 2 - 2

3. Allopurinol: contraindications and dosage

   Newsletter Article 09 February 2013 Pages: 2 - 3

4. Amiodarone

   Newsletter Article 09 February 2013 Pages: 3 - 3

5. Amphetamine abuse

   Newsletter Article 09 February 2013 Pages: 3 - 3

6. Anti-inflammatories, non-steroidal

   Newsletter Article 09 February 2013 Pages: 3 - 4

7. Antilymphocyte globulin

   Newsletter Article 09 February 2013 Pages: 4 - 4

8. Atenolol interaction see Quinidine interaction

   Newsletter Article 09 February 2013 Pages: 4 - 4

9. Benzodiazepines see Buprenorphine

   Newsletter Article 09 February 2013 Pages: 4 - 4

10. Betaxolol

    Newsletter Article 09 February 2013 Pages: 4 - 4

11. Buprenorphine interaction

    Newsletter Article 09 February 2013 Pages: 4 - 4

12. Captopril/enalapril

    Newsletter Article 09 February 2013 Pages: 4 - 5

13. Cefapirin

    Newsletter Article 09 February 2013 Pages: 5 - 5

14. Clonazepam

    Newsletter Article 09 February 2013 Pages: 5 - 5

15. Cotrimoxazole/vancomycin

    Newsletter Article 09 February 2013 Pages: 5 - 5

16. Cyclosporin interaction

    Newsletter Article 09 February 2013 Pages: 5 - 5

17. Cyclosporin see Josamycin

    Newsletter Article 09 February 2013 Pages: 5 - 5

18. Cytarabine

    Newsletter Article 09 February 2013 Pages: 6 - 6

19. Digoxin

    Newsletter Article 09 February 2013 Pages: 6 - 6

20. Enalapril see Captopril

    Newsletter Article 09 February 2013 Pages: 6 - 6

21. Etretinate

    Newsletter Article 09 February 2013 Pages: 6 - 7

22. Gold/penicillamine

    Newsletter Article 09 February 2013 Pages: 7 - 7

23. Hydralazine

    Newsletter Article 09 February 2013 Pages: 7 - 7

24. Indomethacin

    Newsletter Article 09 February 2013 Pages: 7 - 7

25. Isosorbide mononitrate

    Newsletter Article 09 February 2013 Pages: 7 - 7

26. Josamycin interaction

    Newsletter Article 09 February 2013 Pages: 8 - 8

27. Mepacrine

    Newsletter Article 09 February 2013 Pages: 8 - 8

28. Methotrexate

    Newsletter Article 09 February 2013 Pages: 8 - 8

29. Methyldopa

    Newsletter Article 09 February 2013 Pages: 8 - 8

30. Niflumic acid

    Newsletter Article 09 February 2013 Pages: 8 - 9

31. Penicillamine

    Newsletter Article 09 February 2013 Pages: 9 - 9

32. Penicillamine see Gold

    Newsletter Article 09 February 2013 Pages: 9 - 9

33. Phenelzine

    Newsletter Article 09 February 2013 Pages: 9 - 9

34. Pristinamycin see Cyclosporin

    Newsletter Article 09 February 2013 Pages: 9 - 9

35. Procainamide

    Newsletter Article 09 February 2013 Pages: 9 - 9

36. Propoxur overdose

    Newsletter Article 09 February 2013 Pages: 9 - 10

37. Pyrazinamide

    Newsletter Article 09 February 2013 Pages: 10 - 10

38. Quinidine interaction

    Newsletter Article 09 February 2013 Pages: 10 - 10

39. Salicylates

    Newsletter Article 09 February 2013 Pages: 10 - 10

40. Tocainide

    Newsletter Article 09 February 2013 Pages: 10 - 11

41. Tranylcypromine

    Newsletter Article 09 February 2013 Pages: 11 - 11

42. Tricyclic antidepressants

    Newsletter Article 09 February 2013 Pages: 11 - 11

43. Vaccine, influenza virus

    Newsletter Article 09 February 2013 Pages: 11 - 11

44. Vancomycin

    Newsletter Article 09 February 2013 Pages: 11 - 12

45. Vancomycin see Cotrimoxazole

    Newsletter Article 09 February 2013 Pages: 12 - 12

46. Citations

    Newsletter Article 09 February 2013 Pages: 12 - 12